UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005819 |
|---|---|
| Receipt number | R000006881 |
| Scientific Title | Phase II clinical study of HLA-A*2402-restricted survivin-derived peptide vaccine therapy for patients with recurrent non-muscle-invasive bladder cancer |
| Date of disclosure of the study information | 2011/06/21 |
| Last modified on | 2015/12/21 17:39:48 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/06/21 15:18:36 | ||
| 2 | Update | 2011/12/27 07:59:39 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2015/12/21 17:39:48 | Last name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person Address Address Name of person sending information Name of person sending information Address |
